Pérault C, Schvartz C, Wampach H, Liehn J C, Delisle M J
Nuclear Medicine and Biophysics Unit, Jean Godinot Institute, Reims, France.
J Nucl Med. 1997 Aug;38(8):1234-42.
Superimposition of SPECT and computed tomography (CT) slices from the thoracoabdominal region was achieved without the use of external markers for 14 studies in 13 patients with endocrine carcinoma. Technical feasibility and clinical validation of this retrospective fusion method were assessed.
Patients had a history of thyroid cancer or of carcinoid tumor. To detect tumor sites, CT scan and dual-isotope tomoscintigraphy were performed, with 99mTc-hydroxymethylene diphosphonate for bone scintigraphy and with 111In-pentetreotide, 131I or 131I-metaiodobenzylguanidine for tumor scintigraphy (TS). A superimposition method previously developed for the pelvic region was adapted to the nonrigid thoraco-abdominal region. CT-bone scintigraphy and CT-TS superimposed images were obtained. Clinical validation of the information obtained from the superimposed images was obtained from surgery or follow-up imaging studies performed after clinical evolution of the disease process.
Reliable and reproducible registration was achieved in all patients. CT-TS superimposed images produced accurate localization of abnormal TS foci. Accuracy was limited primarily by variable relative displacements of the thoracoabdominal organs. For 10 sites in 8 patients, localization and/or characterization obtained from CT-TS images was confirmed by a reference technique. Superimposition enabled the localization of tumor sites that otherwise could not have been suspected from CT alone and allowed the characterization of CT suspicious masses and the confirmation of CT positive sites. Nonspecific tumor TS uptake sites were also localized.
With standard CT and dual-isotope SPECT acquisitions, SPECT-CT fusion is feasible in the thoracoabdominal region without the use of external markers. Fused images were validated in 8 patients for 10 sites. The use of this technique could probably improve the management and care of patients with endocrine carcinoma.
在13例内分泌癌患者的14项研究中,未使用外部标记物实现了胸腹部区域单光子发射计算机断层扫描(SPECT)与计算机断层扫描(CT)切片的叠加。评估了这种回顾性融合方法的技术可行性和临床有效性。
患者有甲状腺癌或类癌病史。为检测肿瘤部位,进行了CT扫描和双同位素断层闪烁显像,用99m锝 - 羟亚甲基二膦酸盐进行骨闪烁显像,用111铟 - 喷替酸五肽、13I或131I - 间碘苄胍进行肿瘤闪烁显像(TS)。先前为盆腔区域开发的叠加方法适用于非刚性的胸腹部区域。获得了CT - 骨闪烁显像和CT - TS叠加图像。从叠加图像获得的信息的临床有效性通过手术或疾病临床进展后进行的随访影像学研究得到证实。
所有患者均实现了可靠且可重复的配准。CT - TS叠加图像对异常TS病灶进行了准确定位。准确性主要受胸腹部器官相对位移变化的限制。在8例患者的10个部位,通过参考技术证实了从CT - TS图像获得的定位和/或特征。叠加能够定位仅靠CT无法怀疑的肿瘤部位,并能够对CT可疑肿块进行特征描述以及确认CT阳性部位。非特异性肿瘤TS摄取部位也得到了定位。
采用标准CT和双同位素SPECT采集,无需使用外部标记物,SPECT - CT融合在胸腹部区域是可行的。融合图像在8例患者的10个部位得到了验证。使用该技术可能会改善内分泌癌患者的管理和护理。